1. Home
  2. SPRY vs MMI Comparison

SPRY vs MMI Comparison

Compare SPRY & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • MMI
  • Stock Information
  • Founded
  • SPRY 2015
  • MMI 1971
  • Country
  • SPRY United States
  • MMI United States
  • Employees
  • SPRY N/A
  • MMI N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • MMI Real Estate
  • Sector
  • SPRY Health Care
  • MMI Finance
  • Exchange
  • SPRY Nasdaq
  • MMI Nasdaq
  • Market Cap
  • SPRY 1.4B
  • MMI 1.2B
  • IPO Year
  • SPRY N/A
  • MMI 2013
  • Fundamental
  • Price
  • SPRY $15.69
  • MMI $30.73
  • Analyst Decision
  • SPRY Strong Buy
  • MMI Sell
  • Analyst Count
  • SPRY 4
  • MMI 1
  • Target Price
  • SPRY $28.75
  • MMI $30.00
  • AVG Volume (30 Days)
  • SPRY 1.2M
  • MMI 149.5K
  • Earning Date
  • SPRY 08-05-2025
  • MMI 08-06-2025
  • Dividend Yield
  • SPRY N/A
  • MMI 1.63%
  • EPS Growth
  • SPRY N/A
  • MMI N/A
  • EPS
  • SPRY N/A
  • MMI N/A
  • Revenue
  • SPRY $97,122,000.00
  • MMI $711,994,000.00
  • Revenue This Year
  • SPRY N/A
  • MMI $11.69
  • Revenue Next Year
  • SPRY $140.40
  • MMI $24.07
  • P/E Ratio
  • SPRY N/A
  • MMI N/A
  • Revenue Growth
  • SPRY 971120.00
  • MMI 14.79
  • 52 Week Low
  • SPRY $7.55
  • MMI $27.61
  • 52 Week High
  • SPRY $18.51
  • MMI $42.80
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 60.81
  • MMI 54.85
  • Support Level
  • SPRY $14.77
  • MMI $29.67
  • Resistance Level
  • SPRY $16.23
  • MMI $31.01
  • Average True Range (ATR)
  • SPRY 0.73
  • MMI 0.83
  • MACD
  • SPRY 0.12
  • MMI 0.19
  • Stochastic Oscillator
  • SPRY 84.68
  • MMI 80.87

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About MMI Marcus & Millichap Inc.

Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.

Share on Social Networks: